MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study-Reference-Cited by-同舟云学术

MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study

Published:2018-06 Issue:10140 Volume:391 Page:2607-2618
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ambery Philip,Parker Victoria E,Stumvoll Michael,Posch Maximilian G,Heise Tim,Plum-Moerschel Leona,Tsai Lan-Feng,Robertson Darren,Jain Meena,Petrone Marcella,Rondinone Cristina,Hirshberg Boaz,Jermutus Lutz

Publisher

Elsevier BV

Subject

General Medicine

Reference61 articles.

1. Standards of medical care in diabetes—2017;American Diabetes Association;Diabetes Care,2017

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UKPDS Group;Lancet,1998

3. UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients;UKPDS Group;Metabolism,1990

4. Preventing diabetes complications: are we too glucocentric?;Mann;Int J Clin Pract,2010

5. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin;Knowler;N Engl J Med,2002

Cited by 258 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis;Clinical Gastroenterology and Hepatology;2024-09

2. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17

3. Glucagon promotes increased hepatic mitochondrial oxidation and pyruvate carboxylase flux in humans with fatty liver disease;Cell Metabolism;2024-08

4. Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists;Frontiers in Endocrinology;2024-07-24

5. The Efficacy of Pharmacotherapy in the Treatment of Obesity in Patients With Type 2 Diabetes: A Systematic Review;Cureus;2024-07-24